Absci (ABSI) announces a collaboration agreement with AstraZeneca to develop an AI-designed antibody for an undisclosed oncology target. The stock rises 13%.
Carnival (NYSE: CCL) (NYSE: CUK) shares have climbed 95% this year, but they're still trading way below their pre-pandemic levels. Things weren't easy for Carnival at the start of the health crisis since it was forced to halt sailings -- and debt ballooned so the company could stay afloat. Carnival's latest earnings reports offer us reason to be optimistic.
Market performance hangs on U.S. vaccination rates for these three companies.